Combinations of anti-LFA-1, everolimus, anti-CD40 ligand, and allogeneic bone marrow induce central transplantation tolerance through hemopoietic chimerism, including protection from chronic heart allograft rejection (Q45158598)

From Wikidata
Jump to navigation Jump to search
scientific article published in December 2004
edit
Language Label Description Also known as
English
Combinations of anti-LFA-1, everolimus, anti-CD40 ligand, and allogeneic bone marrow induce central transplantation tolerance through hemopoietic chimerism, including protection from chronic heart allograft rejection
scientific article published in December 2004

    Statements

    Combinations of anti-LFA-1, everolimus, anti-CD40 ligand, and allogeneic bone marrow induce central transplantation tolerance through hemopoietic chimerism, including protection from chronic heart allograft rejection (English)
    Barbara Metzler
    Patrick Gfeller
    Marc Bigaud
    Jianping Li
    Grazyna Wieczorek
    Christoph Heusser
    Philip Lake
    Andreas Katopodis
    1 December 2004
    7025-7036

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit